Back
Repligen Stock Predictions
Sponsored
RGEN
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
56
RGEN
Repligen
Last Price:
145.44
Seasonality Move:
9.8%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Repligen Stock Forecast
- Over the next 52 weeks, Repligen has on average historically risen by 23.1% based on the past 38 years of stock performance.
- Repligen has risen higher in 22 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
-
Is Repligen Stock Undervalued?
The current Repligen [RGEN] share price is $145.95. The Score for RGEN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal. - RGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Repligen Stock Go Up Next Year?
- Over the next 52 weeks, Repligen has on average historically risen by 23.1% based on the past 38 years of stock performance.
Repligen Stock Rating
Buy
56
Repligen (RGEN)
is a Buy
Is Repligen overpriced?
- Repligen has risen higher in 22 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
Repligen Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com
52-Week Data
52-Week High:
211.13
52-Week Low:
113.50
Prediction Charts
Market Cap:
8.17B
Price in USD:
145.95
Volume:
365K
Beta:
0.97
Technical Analysis
SMA50:
141.89
SMA100:
140.37
SMA200:
159.44
52-Wk Change:
-2.93%
Stock Predictions
-
Is Repligen stock public?
Yes, Repligen is a publicly traded company. -
What is the Repligen stock quote today?
The Repligen stock price is 145.95 USD today. -
How to buy Repligen stock online?
You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 143.04 | 138.17 | 143.38 | 136.94 |
Oct-18 | 142.22 | 146.95 | 147.47 | 141.28 |
Oct-21 | 145.47 | 149.21 | 149.47 | 143.92 |
Oct-22 | 145.00 | 144.14 | 150.15 | 142.14 |
Oct-23 | 143.86 | 137.48 | 143.86 | 137.36 |
Oct-24 | 138.63 | 135.18 | 138.63 | 134.89 |
Oct-25 | 135.47 | 135.45 | 137.58 | 134.28 |
Oct-28 | 137.50 | 137.21 | 138.24 | 135.07 |
Oct-29 | 135.89 | 134.90 | 138.96 | 133.58 |
Oct-30 | 133.56 | 136.41 | 139.25 | 133.56 |
Oct-31 | 135.08 | 134.24 | 137.50 | 134.12 |
Nov-1 | 134.27 | 138.61 | 138.79 | 134.27 |
Nov-4 | 138.64 | 139.67 | 140.74 | 136.41 |
Nov-5 | 138.32 | 145.95 | 146.03 | 138.32 |
Repligen Earnings
Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.
Repligen Forecast Revenue Growth
Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.38 per share.
* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.